Histone Deacetylase Inhibition Attenuates Cardiac Hypertrophy and Fibrosis through Acetylation of Mineralocorticoid Receptor in Spontaneously Hypertensive Rats-Reference-Cited by-同舟云学术

Histone Deacetylase Inhibition Attenuates Cardiac Hypertrophy and Fibrosis through Acetylation of Mineralocorticoid Receptor in Spontaneously Hypertensive Rats

Published:2015-02-09 Issue:5 Volume:87 Page:782-791
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Kang Seol-Hee,Seok Young Mi,Song Min-ji,Lee Hae-Ahm,Kurz Thomas,Kim InKyeom

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference49 articles.

1. Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors

2. Aldosterone and PAI-1: implications for renal injury;Brown;J Nephrol,2002

3. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy

4. HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats

5. Sodium Valproate, a Histone Deacetylase Inhibitor, but Not Captopril, Prevents Right Ventricular Hypertrophy in Rats

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF;Biochemical and Biophysical Research Communications;2024-11

2. Role of histone deacetylase inhibitors in non-neoplastic diseases;Heliyon;2024-07

3. Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis;Pharmacological Reports;2023-11-23

4. Targeting histone deacetylases for heart diseases;Bioorganic Chemistry;2023-09

5. miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach;International Journal of Molecular Sciences;2023-08-26